Biomarin Pharmaceutical (BMRN) Exchange Rate Effect (2014 - 2026)
Biomarin Pharmaceutical's (BMRN) quarterly Exchange Rate Effect came in at $1.4 million in Q1 2026, up 199.58% YoY from $470664.8 in Q1 2025, and up 15.67% on a QoQ basis from $1.2 million in Q4 2025.
Biomarin Pharmaceutical (BMRN) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Biomarin Pharmaceutical (BMRN) has 13 years of Exchange Rate Effect data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Exchange Rate Effect rose 199.58% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $305000.0 (down 79.49% YoY) and the FY2025 annual result came in at -$2.5 million, down 152.19% from the prior year.
- Exchange Rate Effect rose to $1.4 million in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $3.3 million in Q2 2024 to a low of -$3.6 million in Q4 2023.
- A 5-year average of $297588.2 and a median of $739000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 814.81% in 2023, down 5236.62% in 2023.
- Tracing BMRN's Exchange Rate Effect over 5 years: stood at $71000.0 in 2022, then slumped by 5236.62% to -$3.6 million in 2023, then soared by 168.66% to $2.5 million in 2024, then slumped by 51.32% to $1.2 million in 2025, then advanced by 15.67% to $1.4 million in 2026.
- The last three Exchange Rate Effect figures came in at $1.4 million (Q1 2026), $1.2 million (Q4 2025), and $739000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Biomarin Pharmaceutical | 13.04 Bn | 12.16 Bn | 786.91 Mn | -3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.04 Mn |
| Jun 30, 2026 | -3.04 Mn |
| Mar 31, 2026 | 1.41 Mn |
| Mar 31, 2026 | 1.41 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 739,000.00 |
| Sep 30, 2025 | 739,000.00 |
| Jun 30, 2025 | -3.06 Mn |
| Jun 30, 2025 | -3.06 Mn |
| Mar 31, 2025 | -1.42 Mn |
| Mar 31, 2025 | -1.42 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2024 | -2.90 Mn |
| Sep 30, 2024 | -2.90 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Mar 31, 2024 | 1.93 Mn |